Report post
Investing in drug companies awaiting FDA approval can be lucrative. Recently, Eli Lilly's new Alzheimer's drug received FDA approval, boosting its stock. Similarly, Pfizer and Moderna's stocks surged after the FDA approved their booster shots. Additionally, CRISPR Therapeutics' CEO discussed their FDA approval for sickle cell anemia treatment, highlighting another success story. These approvals not only bring hope to patients but also offer investment opportunities in the pharmaceutical sector.

The World's Leading Crypto Trading Platform

Get my welcome gifts